Suman S, Pravalika J, Manjula P, Farooq U. Gender and CVD- Does It Really Matters? Curr Probl Cardiol. 2023;48:101604. https://doi.org/10.1016/j.cpcardiol.2023.101604.
Nguyen AH, Hurwitz M, Sullivan SA, Saad A, Kennedy JLW, Sharma G. Update on sex specific risk factors in cardiovascular disease. Front Cardiovasc Med. 2024. https://doi.org/10.3389/fcvm.2024.1352675.
El Khoudary SR, Aggarwal B, Beckie TM, Hodis HN, Johnson AE, Langer RD, et al. Menopause Transition and Cardiovascular Disease Risk: Implications for Timing of Early Prevention: A Scientific Statement From the American Heart Association. Circulation. 2020;142:e506-32. https://doi.org/10.1161/CIR.0000000000000912.
Kandasamy G, Subramani T, Sam G, Almanasef M, Almeleebia T, Shorog E, et al. Biosocial predictors and blood pressure goal attainment among postmenopausal women with hypertension. Front Cardiovasc Med. 2024. https://doi.org/10.3389/fcvm.2024.1268791.
Radic J, Dogas H, Vuckovic M, Kolak E, Gelemanovic A, Nenadic DB, et al. MEDICATION ADHERENCE AND GENDER DIFFERENCE IN HYPERTENSIVE PATIENTS. J Hypertens. 2023;41:e314. https://doi.org/10.1097/01.hjh.0000942268.39639.01.
Ministére de la santé. Rapport de l’enquête nationale sur les facteurs de risque communs des Maladies Non transmissibles 2017–2018. 2018.
Algabbani FM, Algabbani AM. Treatment adherence among patients with hypertension: findings from a cross-sectional study. Clin Hypertens. 2020;26:18. https://doi.org/10.1186/s40885-020-00151-1.
Kishor R, Kumari S, Prakash R, Chaudhary N, Shyama S, Ahmad S, et al. An assessment of treatment compliance using the Morisky scale-8 tool in adult hypertensive patients of Eastern India. J Family Med Prim Care. 2024;13:924–31. https://doi.org/10.4103/jfmpc.jfmpc_1416_23.
Ferreira PC, Teston EF, Carvalho BG, Silva JLD, Reis PD, Rossi RM, et al. FACTORS ASSOCIATED WITH THERAPEUTIC NON-ADHERENCE AMONG HYPERTENSIVE INDIVIDUALS WHO SEEK EMERGENCY CARE. Cogitare Enferm. 2023;28:e86141. https://doi.org/10.1590/ce.v28i0.90796.
Bhusal L, Deep Pathak B, Dhakal B, Simkhada N, Sharma N, Upadhaya Remi B, et al. Determination of level of self-reported adherence of antihypertensive drug(s) and its associated factors among patient with hypertension at a tertiary care center. J Clin Hypertens (Greenwich). 2022;24:1444–50. https://doi.org/10.1111/jch.14592.
Ashur ST, Shamsuddin K, Shah SA, Bosseri S, Morisky DE. Reliability and known-group validity of the Arabic version of the 8-item Morisky medication adherence scale among type 2 diabetes mellitus patients. East Mediterr Health J. 2015;21:722–8. https://doi.org/10.26719/2015.21.10.722.
Krousel-Wood M, Islam T, Webber LS, Re R, Morisky DE, Muntner P. New medication adherence scale versus pharmacy fill rates in hypertensive seniors. Am J Manag Care. 2009;15:59–66.
Belayachi S, Boukhari FZ, Essayagh F, Terkiba O, Zohoun A, Essayagh M, et al. Non-adherence to antihypertensive drugs and its risk factors among hypertensive patients, Marrakech, Morocco. PLoS Glob Public Health. 2024;4:e0002774. https://doi.org/10.1371/journal.pgph.0002774.
Essayagh T, Essayagh M, Essayagh Sanah. Drug non-adherence in hypertensive patients in Morocco, and its associated risk factors. Eur J Cardiovasc Nurs. 2021. https://doi.org/10.1093/eurjcn/zvaa002.
Abegaz TM, Shehab A, Gebreyohannes EA, Bhagavathula AS, Elnour AA. Nonadherence to antihypertensive drugs: a systematic review and meta-analysis. Med. 2017;96:e5641. https://doi.org/10.1097/MD.0000000000005641.
Zapata ADRL, Piscoya JA, Zapata CJS, Albañil WM. Calidad de Vida y adherencia terapéutica En Un programa de hipertensión arterial. Rev Salud Publica. 2020;22:618–25. https://doi.org/10.15446/rsap.v22n6.88007.
Barletta PH, Magalhães EFSD, Almeida VFD, Moreira JL, Silva MJD, Macedo C, et al. Clinical characteristics and therapeutic adherence of women in a referral outpatient clinic for severe hypertension. Int J Cardiovasc Sci [Internet]. 2021. https://doi.org/10.36660/ijcs.20200417. [cité 20 août 2024].
Sharma D, Goel N, Lehl S, Walia D, Puri S, Shukla K, et al. Prevalence and predictors of medication nonadherence among hypertensive patients. Int J Noncommunicable Dis. 2022;7:71. https://doi.org/10.4103/jncd.jncd_11_22.
Moujahid C, Turman JE, Houradi H, Amahdar L. Scoping review to identify social determinants of maternal health in Morocco. Int J Soc Determin Health Health Serv. 2024;54:151–62. https://doi.org/10.1177/27551938231217589.
Shareinia H, Sadeghmoghadam L, Mokhtarzadeh MR, Zahrayi SM, Jafari N, Noori R. Relationship between polypharmacy and medication adherence in the hypertensive elderly patients. Dis Diagn. 2020;9:153–7. https://doi.org/10.34172/ddj.2020.05.
Dean YE, Motawea KR, Elawady SS, Nuhu K, Shebl MA, Abuzuaiter B, et al. Non-Adherence to Antihypertensive Medications Among the US Population: A Pooled Analysis of 22 Million Patients. Am Heart J. 2024;267:128. https://doi.org/10.1016/j.ahj.2023.08.036.
Hatir AE, Karaoğlu N, Alsancak Y. Investigation of the effects of education on drug compliance and treatment for hypertensive patients. Turk J Fam Med Prim Care. 2022;16:699–710. https://doi.org/10.21763/tjfmpc.1151712.
Ministry of Health in Morocco. HTA et modes de vie sains VF janv 2020.pdf [Internet]. [cité 13 févr 2025]. https://www.sante.gov.ma/Documents/2023/03/HTA%20et%20modes%20de%20vie%20sains%20VF%20janv%202020.pdf?utm_source=chatgpt.com. Consulté le 13 févr 2025.
Khadoura KJ, Shakibazadeh E, Mansournia MA, Aljeesh Y, Fotouhi A. Effectiveness of motivational interviewing on medication adherence among Palestinian hypertensive patients: a clustered randomized controlled trial. Eur J Cardiovasc Nurs. 2021;20:411–20. https://doi.org/10.1093/eurjcn/zvaa015.
Konstantinidis D, Siafi E, Iliakis P, Mihas C, Tatakis F, Tsioufis P, et al. Targeting better hypertension control with the usage of the ESH smartphone application. Eur J Prev Cardiol. 2025;zwaf240. https://doi.org/10.1093/eurjpc/zwaf240.
Jallal M, Serhier Z, Berrami H, Othmani MB, Jallal M, Serhier Z, et al. Current state and prospects of telemedicine in morocco: analysis of Challenges, Initiatives, and regulatory framework. Cureus [Internet] Cureus. 2023. https://doi.org/10.7759/cureus.50963. [cité 29 oct 2025];15.
Boubekri Z, Niyonsaba A, Mouzoun FZ, Jallal M, Serhier Z, Othmani MB. Understanding Patient Perspectives on Mhealth Adoption in Morocco: Willingness, Interest, and Reasons. 2024 International Conference on Circuit, Systems and Communication (ICCSC) [Internet]. Fes, Morocco: IEEE; 2024 [cité 29 oct 2025]. pp. 1–4. https://doi.org/10.1109/ICCSC62074.2024.10616773
Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Retracted: predictive validity of a medication adherence measure in an outpatient setting. J of Clinical Hypertension. 2008;10:348–54. https://doi.org/10.1111/j.1751-7176.2008.07572.x.
Retraction Statement. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens. 2023;25:889–889. https://doi.org/10.1111/jch.14718.